The Clorox Company
CLX · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $15,120 | $14,789 | $18,166 | $20,101 |
| - Cash | $166 | $167 | $226 | $290 |
| + Debt | $3,078 | $2,880 | $2,944 | $3,092 |
| Enterprise Value | $18,032 | $17,502 | $20,884 | $22,903 |
| Revenue | $1,429 | $1,988 | $1,668 | $1,686 |
| % Growth | -28.1% | 19.2% | -1.1% | – |
| Gross Profit | $594 | $921 | $739 | $735 |
| % Margin | 41.6% | 46.3% | 44.3% | 43.6% |
| EBITDA | $189 | $492 | $336 | $315 |
| % Margin | 13.2% | 24.7% | 20.1% | 18.7% |
| Net Income | $80 | $332 | $186 | $193 |
| % Margin | 5.6% | 16.7% | 11.2% | 11.4% |
| EPS Diluted | 0.65 | 2.68 | 1.5 | 1.54 |
| % Growth | -75.7% | 78.7% | -2.6% | – |
| Operating Cash Flow | $93 | $294 | $286 | $180 |
| Capital Expenditures | -$36 | -$75 | -$53 | -$53 |
| Free Cash Flow | $57 | $219 | $233 | $127 |